A full-length cDNA clone of an aphid non-transmissible isolate of plum pox potyvirus (PPV) was rendered biologically active when placed under the control of the cauliflower mosaic virus 35S RNA promoter and the nopaline synthase polyadenylation signal. The cDNA was constructed so that the exact 5' end of the PPV RNA was present at the transcription initiation site.
Biologische Bundesanstalt fur Institut J~r Biochemie und Pflanzenvirologie, Messeweg 11/12, Germany A full-length cDNA clone of an aphid non-transmissible isolate of plum pox potyvirus (PPV) was rendered biologically active when placed under the control of the cauliflower mosaic virus 35S RNA promoter and the nopaline synthase polyadenylation signal. The cDNA was constructed so that the exact 5' end of the PPV RNA was present at the transcription initiation site.
Inoculation of plasmid DNA onto Nicotiana benthamiana led to systemic infection, whereas local lesions were produced in Chenopodium amaranticolor and C.
quinoa, typical of an infection with PPV. Examination of infected plants revealed PPV-specific virus particles as well as viral RNA, the coat protein and the nonstructural large nuclear inclusion protein (NIb).
Potyviruses belong to the largest group of plant viruses and cause serious diseases in a number of economically important crop plants. Members of the potyvirus group are flexuous rods 720 to 900 nm in length (Hollings & Brunt, 1981) and encapsidate a single positive-sense RNA molecule of about 10 kb, attached to a 5'-linked protein (VPg) and including a poly(A) tract at the 3' end. The RNA is translated into a large polyprotein which is subsequently processed by at least two virus-encoded proteases. Upon proteolytic cleavage this polyprotein yields the viral coat protein (CP) and the non-structural proteins helper component-protease, cylindrical inclusion protein and two nuclear inclusion proteins (NIa and NIb). In addition, at least two other gene products which have not yet been identified are predicted from the nucleotide sequence of all potyviruses sequenced (Allison et al., 1986; Balint et al., 1990; Domier et al., 1986; Lain et al., 1989; Maiss et al., 1989; Robaglia et al., 1989) .
The in vitro synthesis of biologically active RNAs from full-length cDNA clones has been reported for two potyviruses (Domier et al., 1989; Riechmann et al., 1990) . Genetic manipulation of full-length cDNA together with the subsequent transcription of infectious RNA provide a powerful tool for the examination of the molecular biology of RNA viruses. Moreover, it has been shown that infectious RNA can be transcribed in vivo by unknown promoters from plasmids containing cDNA copies of RNA 3 of alfalfa mosaic virus (Dore & Pinck, 1988) , tobacco necrosis satellite RNA (van Emmelo et al., 1987) and potato spindle tuber viroid (Crees et al., 1983) . Recently, Mori et al. (1991) have described the infectivity of plasmids containing the 35S RNA promoter of cauliflower mosaic virus (CaMV) upstream of fulllength cDNAs of all three brome mosaic virus (BMV) RNAs. Also, Commandeur et al. (1991) have demonstrated the infectivity of clones containing the 35S RNA promoter and cDNAs of RNA 3 and RNA 4 of beet necrotic yellow vein virus when complemented with a virus isolate which contains only RNA 1 and RNA 2. In this paper, the construction of a plasmid containing a full-length cDNA of an aphid non-transmissible isolate of plum pox potyvirus (PPV-NAT; Maiss et al., 1989) linked to the 35S RNA promoter of CaMV is described. PPV host plants inoculated with this plasmid produced symptoms that were indistinguishable from those shown by virus-infected plants. This offers the possibility of investigating genome expression, replication and pathogenesis, as an alternative to in vitro transcription of RNA from full-length clones.
PPV-NAT was propagated in Nicotiana clevelandii and N. benthamiana plants. Virus purification and RNA extraction were carried out as described previously (Maiss et al., 1988) . Escherichia coli NM 522 was used for the cloning of all plasmids, and E. coli strains CJ 236 and MV 1190 were used for site-directed mutagenesis (Kunkel et al., 1987) . Plasmids pT7T3 18U, pT7T3 19U and pCaMVCN were purchased from Pharmacia/LKB.
The strategy for the construction of a full-length cDNA clone of PPV-NAT is outlined in Fig. 1 (a) . Briefly, cDNA clones (Maiss et al., 1989) were joined by ligating fragments from overlapping clones sharing common restriction endonuclease sites. The 3' end derived from the original clone, pPPV-NAT65, contained a poly(A) tail of approximately 40 nucleotides Short communication ApaLI; C, ClaI; K, KpnI; P. PstI; Pv, Pvul; S, Sail; Ss, SstI. (b) Sequences surrounding the transcription initiation site, before (p35S5'. 16) and after (p35S5') removal of foreign nucleotides. The end of the 35S RNA promoter is boxed and the start of the PPV-NAT sequence is indicated (numbered as nucleotide + 1), followed by an arrow. (c) Replacement of the truncated CAT gene by a KpnI-PstI fragment of pT7-9.2 to generate p35SPPV-NAT.
followed by 20 cytosine residues. The cytosine residues were removed and the poly(A) tract elongated to 82 residues, giving pT7-9.2. To clone the extreme 5' end of the PPV RNA, which was not present in the first set of cDNA clones, a series of recombinant plasmids was obtained by primer-directed cDNA synthesis. First strand cDNA synthesis was primed with the oligodeoxynuclotide 5' dCAATAA-T A T G A G G G G A T 3' (complementary to nucleotides 566 to 582 of the PPV-NAT sequence; Maiss et al., 1989) . To prime second strand synthesis, and a 25-mer, 5' dTTTAAAATATAAAAACTCAACACAA 3', was used to create a DraI site (TTT/AAA) at the exact 5' end of the PPV-NAT cDNA. Double-stranded cDNA was digested with KpnI and annealed to phagemid pT7T3 18U digested with KpnI and HinclI, creating plasmids containing inserts of PPV-NAT from nucleotides 1 to 565. The sequence of selected clones was confirmed by sequencing, and the clone pPPV-NAT5'4 was chosen for further constructions.
A 454 bp fragment containing the 35S promoter of plasmid pCaMVCN digested with HindlII and BamHI was ligated to pT7T3 19U cut with HindlII and BamHI to give p35S. This plasmid was cleaved with SalI and end-filled with the Klenow fragment of DNA polymerase I. In a second step, cleavage with EcoRI was performed, pPPV-NAT5"4 was cleaved with EcoRI and DraI and the resulting fragment was ligated to p35S. Non-viral nucleotides between the transcription initiation site of the 35S promoter and the first nucleotide of PPV-NAT (Fig. l b) were removed by site-directed mutagenesis (Kunkel et al., 1987) 
using the oligodeoxynucleotide primer 5' d T G T G T T G A G T T T T T A -T A T T T T C C T C T C C A A A T G A A A 3'
, to give p35S5'. This clone was digested with EcoRI and ligated to an EcoRI fragment of pCaMVCN containing part of the chloramphenicol acetyltransferase (CAT) gene and the nopaline synthase (NOS) polyadenylation signal, giving p35S5'NOS. Finally, a PstI-KpnI fragment of pT7-9.2 was ligated to p35S5'NOS giving p35SPPV-NAT. Plasmid DNA from p35SPPV-NAT was prepared from E. coli using the QIAGEN plasmid purification kit according to the manufacturer's instructions. The DNA was adjusted to 1 pg/~tl in sterilized water and a total amount of 10 p.g DNA was inoculated with a glass spatula onto two carborundum-dusted leaves of 4 to 6-week-old N. benthamiana seedlings, or onto two leaves of 8-week-old Chenopodium amaranticolor and C. quinoa plants.
Detection of PPV by immune electron microscopy (IEM) was performed as described by Milne & Lesemann (1984) . Ten to 12 days after inoculation, ELISA was performed according to Casper & Meyer (1981) using anti-PPV rabbit antibodies labelled with alkaline phosphatase. For detection of CP and NIb in Western blots, total phenol-soluble plant protein, prepared by a method modified from van Etten et al. (1979) , was subjected to SDS-PAGE (Laemmli, 1970) . Samples (20 to 30 ~tg) of total protein were separated on 10~ gels and electroblotted onto nitrocellulose. Membranes were subsequently incubated with anti-PPV rabbit antibodies labelled with alkaline phosphatase or with anti-PPV NIb rabbit antibodies, produced by injecting purified fusion proteins of fl-galactosidase and NIb into rabbits (A. Handschick & E. Maiss, unpublished results), and developed according to Adam et al. (1987 (1989) . Samples (approximately 4 ~tg) of total RNA were glyoxal-denatured, separated on a l~ agarose gel and blotted onto nitrocellulose (Sambrook et al., 1989) . Blots were hybridized with a random primed labelled insert of pPPV-NAT65. A full-length eDNA clone of PPV-NAT was cloned downstream of the 35S RNA promoter of CaMV. The transcription initiation site of the promoter was placed next to the first nucleotide of the PPV-NAT sequence to make sure that there would be no extra nucleotides at the 5' end of the transcript generated in vivo, because the presence of more than five non-viral nucleotides at the 5' end of BMV RNAs synthesized in vitro interfered with the infectivity of the transcripts (Janda et al., 1987) . All constructs tested initially failed to establish symptoms on N. benthamiana. To verify the integrity of the large open reading frame of PPV, recloning and expression of different parts of the full-length eDNA in the expression vector pEX-2 and derivatives were carried out. This led to the detection of one expression plasmid, containing nucleotides 2211 to 3627 and encoding a fusion protein of an expected M~ of 91-4K, but which yielded only a truncated protein of approximately 70K. Sequence analysis revealed an insertion of one cytosine residue at nucleotide 3147 producing a frameshift and termination at a UAG at nucleotides 3206 to 3208. The region of nucleotides 565 to 4237 was reconstructed from the original clones (Maiss et al., 1988) and used to replace the defective region in p35SPPV-NAT.
The novel plasmid inoculated onto N. benthamiana was infectious and led to the production of virus as determined by several different criteria. The plants showed symptoms 6 to 8 days after inoculation which were indistinguishable from those developed by plants inoculated with virus. Infected plants showed symptoms which began with distortion of the leaves followed by vein yellowing, chlorosis and later necrosis. However, symptoms appeared with a delay of 1 to 3 days compared with virus-inoculated plants. In three independent experiments, 37 of 77 inoculated N. benthamiana plants developed symptoms. Digestion of p35SPPV-NAT with EcoRI and PstI prior to inoculation completely destroyed the infectivity of the plasmid, indicating that intact eDNA was responsible for initiation of the infection. ELISA of protein extracted from plants with symptoms revealed high values, comparable to those from PPVinfected plants, whereas plants without symptoms failed to give any signal (data not shown). Analysis of p35SPPV-NAT-inoculated plants in Western blot experiments revealed readily detectable CP as well as NIb antigen, identical in size to proteins derived from virus- infected plants (Fig. 2a) . Northern blot analysis of RNA from p35SPPV-NAT-inoculated plants with symptoms confirmed the production of viral RNA (Fig. 2b) . Sap from systemically infected leaves of p35SPPV-NATtreated plants was infectious and produced virus-specific symptoms when passaged into further N. benthamiana seedlings, indicating that the progeny virus of the p35SPPV-NAT DNA is not phenotypically different from the original virus. Filamentous particles and cylindrical inclusion proteins were observed in crude sap preparations of infected N. benthamiana plants. Virus particles were trapped and decorated with an anti-PPV rabbit antiserum for detection by IEM (Fig. 3) . Measurement of the particle length of virions from p35SPPV-NAT-and PPVinoculated plants gave average values of 840 nm and 861 nm, respectively. Particles from p35SPPV-NATinoculated plants were indistinguishable in morphology from virions observed from plants infected with PPV. C. amaranticolor and C. quinoa plants developed 15 to 70 local lesions per leaf 12 to 16 days after inoculation with p35SPPV-NAT. The lesions showed the typical characteristics of an infection with PPV. In addition, virus particles from those lesions were readily identifiable by IEM.
The clone p35SPPV-NAT was able to initiate systemic and local infections when the plasmid DNA was mechanically applied to N. benthamiana, C. amaranticolor and C. quinoa plant leaves. Similar results have been obtained using 35S RNA promoter constructs in the case of BMV (Mori et al., 1991) with a local lesion host. In contrast to our observations with p35SPPV-NAT, inoculation of systemic host plants with the BMV constructs failed to give systemic symptoms. The lengths of the in vivo transcripts of the constructs of Mori et al. (1991) and Commandeur et al. (1991) were approximately 1.5 to 3-5 kb. Considerably larger transcripts must have been synthesized in the case of PPV, indicating that no limitation in the length of transcripts exists (at least to 10 kb) when using the CaMV 35S RNA promoter for foreign sequences. Not all inoculated plants became infected or developed symptoms, probably due to variability of the plant material and the inoculation procedure. However, in one experiment the frequency of infection was 100 ~. Optimization of the procedure may lead to a consistently high infection rate.
The inoculation and infection of plants with fulllength cDNA copies of RNA plant viruses, driven by a promoter which is recognized in plant cells, bypasses the difficulties o f R N A t r a n s c r i p t i o n in vitro, especially the n e e d for synthetic cap structures. T h e supply o f viral R N A t r a n s c r i b e d f r o m a p l a s m i d w i t h i n the p l a n t cell m a k e s a D N A system s u p e r i o r to n o r m a l R N A t r a n s c r i p t s w h e n only v e r y low i n f e c t i o n rates are o b t a i n a b l e .
T h e p 3 5 S P P V -N A T system will be v a l u a b l e to i n v e s t i g a t i o n s o f the g e n o m e e x p r e s s i o n a n d r e p l i c a t i o n o f potyviruses. M o r e o v e r , it will offer a m e a n s to i n v e s t i g a t e effects like t r a n s c a p s i d a t i o n a n d heterologous encapsidation, as well as the effects of recombination between transgenic plant genomes and viral sequences. In public and scientific discussion the focus is on risk assessment of genetically engineered organisms, especially transgenic plants containing viral sequences for CP-mediated cross-protection (de Zoeten, 1991).
